Pfizer boosted its guidance for the year, citing momentum in newly-launched and acquired products that helped offset declining sales for its Covid-19 vaccine and treatments. on.wsj.com/3WiUzSQ
Pfizer Raises Forecast on Momentum With New Products
Pfizer boosted its guidance for the year, citing momentum in newly-launched and acquired products that helped offset declining sales for its Covid-19 vaccine and treatments.
on.wsj.com
November 3, 2026 at 12:32 PM
Pfizer boosted its guidance for the year, citing momentum in newly-launched and acquired products that helped offset declining sales for its Covid-19 vaccine and treatments. on.wsj.com/3WiUzSQ
So this hit my LinkedIn this week and I realized that no Canadian NHL team has won the Stanley Cup since I’ve been employed at Pfizer #GoBruins!
November 1, 2026 at 8:43 PM
So this hit my LinkedIn this week and I realized that no Canadian NHL team has won the Stanley Cup since I’ve been employed at Pfizer #GoBruins!
Pfizer Leads with Earnings Beat, S&P Gains 0.23%
The stock market showed mixed signals today, characterized by Pfizer exceeding earnings expectations by $0.14 per share, which contributed positively to…
https://newsstocks.live/analysis/pfizer-leads-with-earnings-beat-sp-gains-023 #Finance #Markets
The stock market showed mixed signals today, characterized by Pfizer exceeding earnings expectations by $0.14 per share, which contributed positively to…
https://newsstocks.live/analysis/pfizer-leads-with-earnings-beat-sp-gains-023 #Finance #Markets
November 3, 2026 at 8:10 PM
Pfizer Leads with Earnings Beat, S&P Gains 0.23%
The stock market showed mixed signals today, characterized by Pfizer exceeding earnings expectations by $0.14 per share, which contributed positively to…
https://newsstocks.live/analysis/pfizer-leads-with-earnings-beat-sp-gains-023 #Finance #Markets
The stock market showed mixed signals today, characterized by Pfizer exceeding earnings expectations by $0.14 per share, which contributed positively to…
https://newsstocks.live/analysis/pfizer-leads-with-earnings-beat-sp-gains-023 #Finance #Markets
Pfizer (PFE) Beats Earnings by $0.14 and Tops Revenue Estimates
Pfizer (PFE) reported earnings that exceeded analyst expectations by $0.14 per share. The company also posted revenue figures …
https://newsstocks.live/news/pfizer-pfe-beats-earnings-by-014-and-tops-revenue-estimates #Finance #Markets
Pfizer (PFE) reported earnings that exceeded analyst expectations by $0.14 per share. The company also posted revenue figures …
https://newsstocks.live/news/pfizer-pfe-beats-earnings-by-014-and-tops-revenue-estimates #Finance #Markets
November 3, 2026 at 12:02 PM
Pfizer (PFE) Beats Earnings by $0.14 and Tops Revenue Estimates
Pfizer (PFE) reported earnings that exceeded analyst expectations by $0.14 per share. The company also posted revenue figures …
https://newsstocks.live/news/pfizer-pfe-beats-earnings-by-014-and-tops-revenue-estimates #Finance #Markets
Pfizer (PFE) reported earnings that exceeded analyst expectations by $0.14 per share. The company also posted revenue figures …
https://newsstocks.live/news/pfizer-pfe-beats-earnings-by-014-and-tops-revenue-estimates #Finance #Markets
Pfizer hikes full-year outlook, taps company veteran as new CFO
Pfizer hikes full-year outlook, taps company veteran as new CFO
Pfizer announced that Cecile Guegan, who has held various leadership roles at the company over the last 20 years, stepped in as CFO this month.
cnb.cx
November 3, 2026 at 12:07 PM
Pfizer hikes full-year outlook, taps company veteran as new CFO
In the state legislature, Joe Mitchell voted against capping the cost of insulin and then took a check from Pfizer. On Tuesday, we need to send people who will champion working people, not the ultra wealthy and big corporations.
October 31, 2026 at 12:12 AM
In the state legislature, Joe Mitchell voted against capping the cost of insulin and then took a check from Pfizer. On Tuesday, we need to send people who will champion working people, not the ultra wealthy and big corporations.
This is disputed by Pfizer 🔷️
October 31, 2026 at 8:06 AM
This is disputed by Pfizer 🔷️
Got a job for you, 621. The Pfizer Group has put in a contract.
October 31, 2026 at 6:10 PM
Got a job for you, 621. The Pfizer Group has put in a contract.
pfizer: literally not feeling it at all yet
flu arm: owwwwww
flu arm: owwwwww
November 3, 2026 at 10:37 PM
pfizer: literally not feeling it at all yet
flu arm: owwwwww
flu arm: owwwwww
Stocks making the biggest moves premarket: Pfizer, Apple, Palantir, Zebra Technologies & more
Stocks making the biggest moves premarket: Pfizer, Apple, Palantir, Zebra Technologies & more
These are the stocks posting the largest moves premarket.
cnb.cx
November 3, 2026 at 12:52 PM
Stocks making the biggest moves premarket: Pfizer, Apple, Palantir, Zebra Technologies & more
Grokkk should be able to replace Pfizer in 3 months maybe 6 months definitely. Just need to build the world’s largest pharma plant. Tesla Pharma. It just makes so much sense because of the moon mission.
November 1, 2026 at 3:42 PM
Grokkk should be able to replace Pfizer in 3 months maybe 6 months definitely. Just need to build the world’s largest pharma plant. Tesla Pharma. It just makes so much sense because of the moon mission.
1/2
Hey Buddy…
Funny her husband’s Pfizer bond holding drew scrutiny because she serves on a Senate committee with health-policy jurisdiction.
Now, that is a plausible appearance-of-conflict concern,
www.washingtonsun.com/senate/susan...
Hey Buddy…
Funny her husband’s Pfizer bond holding drew scrutiny because she serves on a Senate committee with health-policy jurisdiction.
Now, that is a plausible appearance-of-conflict concern,
www.washingtonsun.com/senate/susan...
November 1, 2026 at 9:41 PM
1/2
Hey Buddy…
Funny her husband’s Pfizer bond holding drew scrutiny because she serves on a Senate committee with health-policy jurisdiction.
Now, that is a plausible appearance-of-conflict concern,
www.washingtonsun.com/senate/susan...
Hey Buddy…
Funny her husband’s Pfizer bond holding drew scrutiny because she serves on a Senate committee with health-policy jurisdiction.
Now, that is a plausible appearance-of-conflict concern,
www.washingtonsun.com/senate/susan...
Stocks making the biggest moves premarket: Revvity, Pfizer, Palantir & more www.cnbc.com/2026/11/03/s...
Stocks making the biggest moves premarket: Pfizer, Apple, Palantir, Zebra Technologies & more
These are the stocks posting the largest moves premarket.
www.cnbc.com
November 3, 2026 at 12:51 PM
Stocks making the biggest moves premarket: Revvity, Pfizer, Palantir & more www.cnbc.com/2026/11/03/s...
pai de uma amiga morreu na semana q liberaram a vacinação para as pessoas da idade dele. se a gente contextualiza o q aconteceu (entre ignorar a pfizer, tentar sabotar a coronavac pq foi o doria q trouxe e querer contrato com a covaxin), tudo fica ainda pior.
November 2, 2026 at 8:30 PM
pai de uma amiga morreu na semana q liberaram a vacinação para as pessoas da idade dele. se a gente contextualiza o q aconteceu (entre ignorar a pfizer, tentar sabotar a coronavac pq foi o doria q trouxe e querer contrato com a covaxin), tudo fica ainda pior.
#$PFE · Pfizer results: $16.6 billion revenue and new cost-cutting plans
Pfizer reported third-quarter 2026 revenue of $16.6 billion and adjusted diluted earnings per share (EPS) of $0.87. Total revenue fell $71 million from the year-ago period. The company noted 7% operational…
#stocks #investing
Pfizer reported third-quarter 2026 revenue of $16.6 billion and adjusted diluted earnings per share (EPS) of $0.87. Total revenue fell $71 million from the year-ago period. The company noted 7% operational…
#stocks #investing
Pfizer results: $16.6 billion revenue and new cost-cutting plans
Pfizer reported third-quarter 2026 revenue of $16.6 billion and adjusted diluted earnings per share (EPS) of $0.87. Total revenue fell $71 million from the year-ago period. The company noted 7% operational growth in its portfolio excluding Comirnaty and Paxlovid.
insiderpost.org
November 3, 2026 at 3:26 PM
#$PFE · Pfizer results: $16.6 billion revenue and new cost-cutting plans
Pfizer reported third-quarter 2026 revenue of $16.6 billion and adjusted diluted earnings per share (EPS) of $0.87. Total revenue fell $71 million from the year-ago period. The company noted 7% operational…
#stocks #investing
Pfizer reported third-quarter 2026 revenue of $16.6 billion and adjusted diluted earnings per share (EPS) of $0.87. Total revenue fell $71 million from the year-ago period. The company noted 7% operational…
#stocks #investing
Just What I Needed being used in a Pfizer commercial just made me feel ancient.
November 2, 2026 at 1:56 AM
Just What I Needed being used in a Pfizer commercial just made me feel ancient.
November 3, 2026 at 12:30 PM
Pfizer hikes full-year outlook on new product growth, taps company veteran as new CFO
replaye.com/pfizer-hikes...
#News #Pfizer #CFO #Investing #Business
replaye.com/pfizer-hikes...
#News #Pfizer #CFO #Investing #Business
Pfizer hikes full-year outlook on new product growth, taps company veteran as new CFO - Replaye
Pfizer announced that Cecile Guegan, who has held various leadership roles at the company over the last 20 years, stepped in as CFO this month.
replaye.com
November 3, 2026 at 9:53 PM
Pfizer hikes full-year outlook on new product growth, taps company veteran as new CFO
replaye.com/pfizer-hikes...
#News #Pfizer #CFO #Investing #Business
replaye.com/pfizer-hikes...
#News #Pfizer #CFO #Investing #Business
Moderna always does this to me when Pfizer does not. Go figure.
October 31, 2026 at 10:54 AM
Moderna always does this to me when Pfizer does not. Go figure.
He was right they is USA and Israel and zios own Pfizer they made billions… blaming China like they always do
October 31, 2026 at 6:38 PM
He was right they is USA and Israel and zios own Pfizer they made billions… blaming China like they always do
Pfizer's Albert Bourla doesn't expect Democratic gains in Congress to change the MFN deals, which run through the end of Trump's term.
Pfizer CEO Bourla says 'I don't expect any changes' to Trump MFN deals if Dems take Congress
Pfizer CEO Albert Bourla says Trump’s MFN pricing deals will hold through the end of the term, even if Democrats win Congress.
endpoints.news
November 3, 2026 at 8:02 PM
Pfizer's Albert Bourla doesn't expect Democratic gains in Congress to change the MFN deals, which run through the end of Trump's term.
Pfizer Raises 2026 Guidance as Eliquis Sales Jump 25 Percent
Pfizer beat third quarter forecasts, lifted its 2026 revenue and profit outlook and confirmed Cecile Guegan as chief financial officer.
Pfizer beat third quarter forecasts, lifted its 2026 revenue and profit outlook and confirmed Cecile Guegan as chief financial officer.
Pfizer Raises 2026 Guidance as Eliquis Sales Jump 25 Percent
Pfizer beat third quarter forecasts, lifted its 2026 revenue and profit outlook and confirmed Cecile Guegan as chief financial officer.
qncnews.com
November 3, 2026 at 12:44 PM
Pfizer Raises 2026 Guidance as Eliquis Sales Jump 25 Percent
Pfizer beat third quarter forecasts, lifted its 2026 revenue and profit outlook and confirmed Cecile Guegan as chief financial officer.
Pfizer beat third quarter forecasts, lifted its 2026 revenue and profit outlook and confirmed Cecile Guegan as chief financial officer.
El calendario de resultados de mañana incluye a Apollo, Eaton, Pfizer y Shopify antes de la apertura. AMD, Amgen, Arista Networks y Booking reportan después del cierre.
November 3, 2026 at 9:20 AM
El calendario de resultados de mañana incluye a Apollo, Eaton, Pfizer y Shopify antes de la apertura. AMD, Amgen, Arista Networks y Booking reportan después del cierre.